Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Multiple Myeloma 14Lymphoma, Large B-Cell, Diffuse 14Lymphoma, Non-Hodgkin 11Leukemia, Myeloid, Acute 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Leukemia, Lymphocytic, Chronic, B-Cell 9Lymphoma, Mantle-Cell 8Lymphoma, Follicular 8Lymphoma, B-Cell 7Glioblastoma 7Hodgkin Disease 6Burkitt Lymphoma 6Lymphoma 5Recurrence 4Prostatic Neoplasms 4Lymphoma, B-Cell, Marginal Zone 4Hematologic Neoplasms 4Breast Neoplasms 4Triple Negative Breast Neoplasms 3Sarcoma 3Ovarian Neoplasms 3Myelodysplastic Syndromes 3Melanoma 3Lymphoma, Large-Cell, Anaplastic 3Leukemia 3Glioma 3Astrocytoma 3Waldenstrom Macroglobulinemia 2Sezary Syndrome 2Sarcoma, Synovial 2

Interventions

Ifosfamide 30Methotrexate 27Doxorubicin 25Cyclophosphamide 24Cisplatin 22Filgrastim 18Etoposide 17Gemcitabine 16Leucovorin 14Magnetic Resonance Spectroscopy 11Temozolomide 10cabozantinib 9apatinib 9Specimen Handling 9Carboplatin 9fludarabine 8X-Rays 8Nivolumab 8Neoadjuvant Therapy 8Irinotecan 8Granulocyte Colony-Stimulating Factor 8Docetaxel 8Zoledronic Acid 7Vincristine 7Sirolimus 7Radiotherapy 7Phantoms, Imaging 7Biopsy 7Topotecan 6Mesna 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Osteosarcoma × Leukapheresis × Clear all
NCT07227571 2026-02-11

Genetically Engineered Cells (FH-FOLR1 ST CAR T Cells) for the Treatment of Advanced Refractory or Recurrent/Progressive Osteosarcoma, FIERCe Trial

Fred Hutchinson Cancer Center

Phase 1 Recruiting
30 enrolled
Sarcoma

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡